Characterization of raloxifene as potential pharmacological agent against SARS-CoV-2 and its variantsDaniela Iaconis(Telethon Institute Of Genetics And Medicine), Andrea R. Beccari(Dompé (Italy))bioRxiv (Cold Spring Harbor Laboratory)October 24, 202110.1101/2021.10.22.465294Cited by 1SaveCiteExport RISWatch citationsRelated PapersThe centrosomal OFD1 protein interacts with the translation machinery and regulates the synthesis of specific targets|Scientific Reports|2017|51DHFR Inhibitors Display a Pleiotropic Anti-Viral Activity against SARS-CoV-2: Insights into the Mechanisms of Action|Viruses|2023|8DHFR Inhibitors Display a Pleiotropic Anti-viral Activity Against SARS-CoV-2: Insights Into the Mechanisms of Action|Preprints.org|2023|3